服务热线
Anti-CD3E;TNFRSF17/CD269/BCMA/TNFRSF13A mAbs [Etentamig Biosimilar] (MABL-4680)
Anti-SARS-CoV-2 Spike RBD mAbs [Etesevimab Biosimilar] (MABL-4681)
Anti-EGFR/ERBB1/HER1;CD3E mAbs [Etevritamab Biosimilar] (MABL-4682)
Anti-TIGIT/WUCAM/VSTM3 mAbs [Etigilimab Biosimilar] (MABL-4683)
Anti-IL13 mAbs [Etokimab Biosimilar] (MABL-4684)
Anti-ITGA4B7 and ITGAEB7 mAbs [Etrolizumab Biosimilar] (MABL-4685)
Anti-ENTPD1/CD39 mAbs [Eurestobart Biosimilar] (MABL-4686)
Anti-CTLA4/CD152 mAbs [Evalstotug Biosimilar] (MABL-4687)
Anti-ANGPTL3 mAbs [Evinacumab Biosimilar] (MABL-4688)
Anti-PCSK9 mAbs [Evolocumab Biosimilar] (MABL-4689)
Anti-TNFRSF9/CD137/4-1BB mAbs [Evunzekibart Biosimilar] (MABL-4690)
Anti-Hepatitis B Surface Antigen mAbs [Exbivirumab Biosimilar] (MABL-4691)
Anti-TMPRSS6/MT2 mAbs [Exerenibart Biosimilar] (MABL-4692)
Anti-SNCA/PARK1/PARK4 mAbs [Exidavnemab Biosimilar] (MABL-4693)
Anti-PDL1/CD274 mAbs [Envafolimab Biosimilar] (MABL-4664)
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn
陕ICP备2021006339号
![Anti-CD3E;TNFRSF17/CD269/BCMA/TNFRSF13A mAbs [Etentamig Biosimilar] (MABL-4680)](/uploads/allimg/2025/11/02/060f6b3027e1c5f3d575cab097fb59ae.png)
![Anti-PDL1/CD274 mAbs [Envafolimab Biosimilar] (MABL-4664)](/uploads/allimg/2025/11/02/e3773bb51013fd1efe80ebf9fcb8d3af.png)